Skip to main content
Clinical Trials/TCTR20231019003
TCTR20231019003
Not yet recruiting
Phase 1

The effects of moderate-intensity aerobic exercise in people with IgA nephropathy:a randomized controlled trial

West China Hospital of Sichuan University0 sites70 target enrollmentOctober 19, 2023

Overview

Phase
Phase 1
Intervention
Not specified
Conditions
IgA nephropathy physical activity
Sponsor
West China Hospital of Sichuan University
Enrollment
70
Status
Not yet recruiting
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
October 19, 2023
End Date
December 31, 2024
Last Updated
last year
Study Type
Interventional
Sex
All

Investigators

Sponsor
West China Hospital of Sichuan University

Eligibility Criteria

Inclusion Criteria

  • IgAN confirmed by renal biopsy;
  • Age over 16 years old, regardless of gender;
  • Patients with eGFR over 15ml/min/1\.73m;
  • Irregular exercise habits in the last year.

Exclusion Criteria

  • 1\.Other autoimmune diseases or secondary kidney diseases, such assystemic lupus erythematosus, systemic sclerosis, rheumatoid arthritis, diabetic nephropathy, cirrhosis, nephrotoxic drugs, etc.
  • 2\.Those on dialysis or those who are expected to be on dialysis within 1 year;
  • 3\.Suffering from other critical diseases such as heart failure, respiratory failure, malignant tumor, severe infection, severe trauma, mental disorders, severe dementia, etc.
  • 4\.Patients who underwent or required hormonal and/or immunosuppressant therapy within 6 months prior to this study were included;
  • 5\.Patients who cannot be followed up regularly;
  • 6\.Patients with musculoskeletal lesions;
  • 7\.pregnant or lactating women.

Outcomes

Primary Outcomes

Not specified

Similar Trials